Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12076
BGSF Inc
BGSF
$60.4M
| $63.6K | ﹤0.01% |
12,128
+1,237
| +11% | +$8.54K |
|
|
OGI
12077
Organigram Holdings
OGI
$173M
| $63.5K | ﹤0.01% |
39,441
+39,420
| +187,714% | +$64.2K |
|
12078
PUT
Outset Medical
OM
$84.8M
| $63.5K | ﹤0.01% |
3,813
+1,013
| +36% | +$12.6K |
|
12079
Planet Green Holdings
PLAG
$12.8M
| $63.5K | ﹤0.01% |
+24,458
| New | +$58.3K |
|
12080
CALL
Aquestive Therapeutics
AQST
$533M
| $63.4K | ﹤0.01% |
17,800
-57,300
| -76% | -$264K |
|
12081
CALL
VanEck Merk Gold Trust
OUNZ
$2.71B
| $63.3K | ﹤0.01% |
2,500
-4,000
| -62% | -$103K |
|
|
AAMI
12082
PUT
Acadian Asset Management
AAMI
$3.28B
| $63.2K | ﹤0.01% |
2,400
+500
| +26% | +$14K |
|
12083
PUT
Invesco S&P 500 Pure Value ETF
RPV
$1.75B
| $63.1K | ﹤0.01% |
+700
| New | +$64.1K |
|
12084
CALL
Outlook Therapeutics
OTLK
$141M
| $63.1K | ﹤0.01% |
33,400
-41,000
| -55% | -$169K |
|
|
XNET
12085
CALL
Xunlei
XNET
$334M
| $63.1K | ﹤0.01% |
31,700
+25,800
| +437% | +$52.3K |
|
12086
CALL
Personalis
PSNL
$1.5B
| $63K | ﹤0.01% |
10,900
-6,000
| -36% | -$27.7K |
|
12087
PUT
American Vanguard Corp
AVD
$62.5M
| $63K | ﹤0.01% |
13,600
+5,900
| +77% | +$31.9K |
|
12088
CALL
Nicolet Bankshares
NIC
$3.75B
| $62.9K | ﹤0.01% |
600
| – | – |
|
12089
DHI Group
DHX
$171M
| $62.9K | ﹤0.01% |
35,554
-35,830
| -50% | -$63.3K |
|
12090
PUT
Verra Mobility
VRRM
$717M
| $62.9K | ﹤0.01% |
2,600
-5,900
| -69% | -$146K |
|
12091
CALL
Independent Bank Corp
IBCP
$850M
| $62.7K | ﹤0.01% |
+1,800
| New | +$63.9K |
|
12092
Scilex Holding
SCLX
$47.5M
| $62.7K | ﹤0.01% |
4,271
-12,762
| -75% | -$324K |
|
12093
CALL
Invesco Leisure and Entertainment ETF
PEJ
$314M
| $62.6K | ﹤0.01% |
1,200
-3,600
| -75% | -$185K |
|
|
FLNT
12094
Fluent
FLNT
$129M
| $62.6K | ﹤0.01% |
24,848
+525
| +2% | +$1.53K |
|
|
CLLS
12095
Cellectis
CLLS
$307M
| $62.6K | ﹤0.01% |
34,786
+7,162
| +26% | +$13.4K |
|
|
DVAX
12096
DELISTED
Dynavax Technologies
DVAX
| $62.5K | ﹤0.01% |
4,894
-438,367
| -99% | -$5.3M |
|
|
AFCG
12097
CALL
AFC Gamma
AFCG
$72.1M
| $62.5K | ﹤0.01% |
+7,500
| New | +$72K |
|
12098
PUT
Shinhan Financial Group
SHG
$35.4B
| $62.5K | ﹤0.01% |
1,900
+1,000
| +111% | +$38.7K |
|
|
NIXX
12099
Nixxy Inc
NIXX
$19.7M
| $62.3K | ﹤0.01% |
11,851
-7,061
| -37% | -$23.4K |
|
|
DM
12100
CALL
DELISTED
Desktop Metal, Inc.
DM
| $62.3K | ﹤0.01% |
26,620
-3,100
| -10% | -$13.1K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.